Your browser doesn't support javascript.
loading
Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer.
Zhang, Allen W; McPherson, Andrew; Milne, Katy; Kroeger, David R; Hamilton, Phineas T; Miranda, Alex; Funnell, Tyler; Little, Nicole; de Souza, Camila P E; Laan, Sonya; LeDoux, Stacey; Cochrane, Dawn R; Lim, Jamie L P; Yang, Winnie; Roth, Andrew; Smith, Maia A; Ho, Julie; Tse, Kane; Zeng, Thomas; Shlafman, Inna; Mayo, Michael R; Moore, Richard; Failmezger, Henrik; Heindl, Andreas; Wang, Yi Kan; Bashashati, Ali; Grewal, Diljot S; Brown, Scott D; Lai, Daniel; Wan, Adrian N C; Nielsen, Cydney B; Huebner, Curtis; Tessier-Cloutier, Basile; Anglesio, Michael S; Bouchard-Côté, Alexandre; Yuan, Yinyin; Wasserman, Wyeth W; Gilks, C Blake; Karnezis, Anthony N; Aparicio, Samuel; McAlpine, Jessica N; Huntsman, David G; Holt, Robert A; Nelson, Brad H; Shah, Sohrab P.
Afiliación
  • Zhang AW; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada; BC Children's Hospital Research, Vancouver, BC V5Z 4H4, Canada; Graduate Bioinformatics Training Program, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • McPherson A; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Milne K; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada.
  • Kroeger DR; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada.
  • Hamilton PT; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada.
  • Miranda A; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada.
  • Funnell T; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada; Graduate Bioinformatics Training Program, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Little N; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada.
  • de Souza CPE; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Laan S; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada.
  • LeDoux S; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada.
  • Cochrane DR; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Lim JLP; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Yang W; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Roth A; Department of Statistics, University of Oxford, Oxford OX1 2JD, UK; Ludwig Institute for Cancer Research, University of Oxford, Oxford OX1 2JD, UK.
  • Smith MA; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Ho J; Department of Anatomical Pathology, Vancouver General Hospital, Vancouver, BC V5Z 1M9, Canada.
  • Tse K; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Zeng T; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Shlafman I; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Mayo MR; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Moore R; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Failmezger H; Centre for Evolution and Cancer, The Institute of Cancer Research, London SM2 5NG, UK; Division of Molecular Pathology, The Institute of Cancer Research, London SM2 5NG, UK.
  • Heindl A; Centre for Evolution and Cancer, The Institute of Cancer Research, London SM2 5NG, UK; Division of Molecular Pathology, The Institute of Cancer Research, London SM2 5NG, UK.
  • Wang YK; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Bashashati A; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Grewal DS; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Brown SD; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4E6, Canada; Genome Science and Technology Program, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Lai D; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Wan ANC; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Nielsen CB; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Huebner C; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Tessier-Cloutier B; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Anglesio MS; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada; Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Bouchard-Côté A; Department of Statistics, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Yuan Y; Centre for Evolution and Cancer, The Institute of Cancer Research, London SM2 5NG, UK; Division of Molecular Pathology, The Institute of Cancer Research, London SM2 5NG, UK.
  • Wasserman WW; BC Children's Hospital Research, Vancouver, BC V5Z 4H4, Canada.
  • Gilks CB; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Karnezis AN; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Aparicio S; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • McAlpine JN; Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Huntsman DG; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Holt RA; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Nelson BH; Deeley Research Centre, BC Cancer, Victoria, BC V8R 6V5, Canada; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8P 3E6, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. Electronic address: bnelson@bccrc.ca.
  • Shah SP; Department of Molecular Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. Electronic address: sshah@bccrc.ca.
Cell ; 173(7): 1755-1769.e22, 2018 06 14.
Article en En | MEDLINE | ID: mdl-29754820
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Linfocitos Infiltrantes de Tumor Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Cell Año: 2018 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Linfocitos Infiltrantes de Tumor Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Cell Año: 2018 Tipo del documento: Article País de afiliación: Canadá